These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 8393838)
1. Correlation between the growth-inhibitory effect of TGF-beta 1 and phenotypic characteristics in a panel of B-cell lines. Altiok A; Ehlin-Henriksson B; Klein E Int J Cancer; 1993 Aug; 55(1):137-40. PubMed ID: 8393838 [TBL] [Abstract][Full Text] [Related]
2. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines. Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341 [TBL] [Abstract][Full Text] [Related]
3. Effect of transforming growth factor-beta 1 and -beta 2 on the proliferation of Burkitt lymphoma and lymphoblastoid cell lines. Altiok A; Bejarano MT; Ruscetti F; Altiok E; Klein G; Klein E Growth Factors; 1991; 4(2):117-28. PubMed ID: 1646619 [TBL] [Abstract][Full Text] [Related]
4. Resistance to TGF-beta1 correlates with a reduction of TGF-beta type II receptor expression in Burkitt's lymphoma and Epstein-Barr virus-transformed B lymphoblastoid cell lines. Inman GJ; Allday MJ J Gen Virol; 2000 Jun; 81(Pt 6):1567-78. PubMed ID: 10811940 [TBL] [Abstract][Full Text] [Related]
5. Loss of transforming growth factor beta 1 receptors and its effects on the growth of EBV-transformed human B cells. Kumar A; Rogers T; Maizel A; Sharma S J Immunol; 1991 Aug; 147(3):998-1006. PubMed ID: 1713611 [TBL] [Abstract][Full Text] [Related]
6. Effect of TGF-beta on the proliferation of B cell lines and on the immortalisation of B cells by EBV. Altiok A; Bejarano MT; Klein E Curr Top Microbiol Immunol; 1990; 166():375-80. PubMed ID: 1963587 [No Abstract] [Full Text] [Related]
7. Local growth of a Burkitt's lymphoma versus disseminated invasive growth of the autologous EBV-immortalized lymphoblastoid cells and their somatic cell hybrids in SCID mice. Walter J; Möller P; Moldenhauer G; Schirrmacher V; Pawlita M; Wolf J Int J Cancer; 1992 Jan; 50(2):265-73. PubMed ID: 1309726 [TBL] [Abstract][Full Text] [Related]
8. Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells. Arvanitakis L; Yaseen N; Sharma S J Immunol; 1995 Aug; 155(3):1047-56. PubMed ID: 7636179 [TBL] [Abstract][Full Text] [Related]
9. Retinoic acid induces persistent, RARalpha-mediated anti-proliferative responses in Epstein-Barr virus-immortalized b lymphoblasts carrying an activated C-MYC oncogene but not in Burkitt's lymphoma cell lines. Cariati R; Zancai P; Quaia M; Cutrona G; Giannini F; Rizzo S; Boiocchi M; Dolcetti R Int J Cancer; 2000 May; 86(3):375-84. PubMed ID: 10760826 [TBL] [Abstract][Full Text] [Related]
10. The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines. Nakagomi H; Dolcetti R; Bejarano MT; Pisa P; Kiessling R; Masucci MG Int J Cancer; 1994 Apr; 57(2):240-4. PubMed ID: 8157362 [TBL] [Abstract][Full Text] [Related]
11. Regulation of germ-line epsilon transcription and induction of epsilon switching in cloned EBV-transformed and malignant human B cell lines by cytokines and CD4+ T cells. Gauchat JF; Gascan H; de Waal Malefyt R; de Vries JE J Immunol; 1992 Apr; 148(7):2291-9. PubMed ID: 1347554 [TBL] [Abstract][Full Text] [Related]
12. Effect of TGF-beta 1 on the EBV-induced transformation of human lymphocyte cultures. Altiok A; Bejarano MT; Klein G; Klein E Int J Cancer; 1992 Mar; 50(5):772-6. PubMed ID: 1312065 [TBL] [Abstract][Full Text] [Related]
13. Characterization of transforming growth factor-beta 1 induced apoptosis in normal human B cells and lymphoma B cell lines. Chaouchi N; Arvanitakis L; Auffredou MT; Blanchard DA; Vazquez A; Sharma S Oncogene; 1995 Oct; 11(8):1615-22. PubMed ID: 7478586 [TBL] [Abstract][Full Text] [Related]
14. Human B-lymphoid cell lines. Nilsson K Hum Cell; 1992 Mar; 5(1):25-41. PubMed ID: 1329931 [TBL] [Abstract][Full Text] [Related]
15. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines. Gibbons DL; Rowe M; Cope AP; Feldmann M; Brennan FM Eur J Immunol; 1994 Aug; 24(8):1879-85. PubMed ID: 8056047 [TBL] [Abstract][Full Text] [Related]
16. Differential expression of nucleoskeleton- and cytoskeleton-associated proteins in Burkitt lymphoma-derived and Epstein-Barr virus-immortalized lymphoblastoid cell lines. Szekely L; Pokrovskaja K; Klein G Cell Growth Differ; 1997 May; 8(5):599-609. PubMed ID: 9149911 [TBL] [Abstract][Full Text] [Related]
17. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss. Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002 [TBL] [Abstract][Full Text] [Related]
18. Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity. Torsteinsdottir S; Masucci MG; Ehlin-Henriksson B; Brautbar C; Ben Bassat H; Klein G; Klein E Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5620-4. PubMed ID: 3016710 [TBL] [Abstract][Full Text] [Related]
19. Isolation of a normal B cell subset with a Burkitt-like phenotype and transformation in vitro with Epstein-Barr virus. Gregory CD; Edwards CF; Milner A; Wiels J; Lipinski M; Rowe M; Tursz T; Rickinson AB Int J Cancer; 1988 Aug; 42(2):213-20. PubMed ID: 2841246 [TBL] [Abstract][Full Text] [Related]
20. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines. Masucci MG; Torsteindottir S; Colombani J; Brautbar C; Klein E; Klein G Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4567-71. PubMed ID: 3037521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]